Nano Dimension (NNDM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Jun, 2026Executive summary
Extraordinary General Meeting scheduled for July 31, 2026, with voting open to shareholders of record as of June 23, 2026.
Proxy materials include proposals from both the board and proposing shareholders, with board recommendations provided.
Voting instructions and proxy card procedures detailed for both direct shareholders and ADR holders.
Voting matters and shareholder proposals
Proposal 1 seeks non-binding approval for continuation of the strategic alternatives review process, recommended FOR by the board.
Proposal 2 involves amending Article 39 of the Articles, recommended FOR by the board.
Proposals 3 and 4 propose adding new Articles 71 and 72, recommended AGAINST by the board.
Proposal 5 seeks dismissal of three named directors and any new directors appointed after May 21, 2026, recommended AGAINST by the board.
Proposal 6, contingent on Proposal 5, proposes electing three new directors to fill resulting vacancies, recommended AGAINST by the board.
Board of directors and corporate governance
Board recommends voting against proposals to dismiss current directors and appoint new ones.
Proxy authorizes designated officers to vote on behalf of shareholders at the meeting and any adjournments.
Latest events from Nano Dimension
- Revenue up 46% to $58.7M, Q2 margin 45.9%, net loss widens, cost cuts to reduce cash burn.NNDM
Q2 2026 - Shareholders face a pivotal vote on Board control, with future input on strategic transactions.NNDM
Proxy filing - Proxy contest seeks board overhaul, annual elections, and more shareholder control over key decisions.NNDM
Proxy filing - Board supports strategic review and declassification, opposes governance and director changes.NNDM
Proxy filing - Proxy contest aims to declassify the board, restrict poison pills, and replace key directors.NNDM
Proxy filing - Proposed merger with Infinite Epigenetics offers a 20% premium and pivots to AI-powered diagnostics.NNDM
Proxy filing - $890M merger forms a Nasdaq-listed AI diagnostics leader targeting the $90–94B U.S. market.NNDM
M&A announcement - Q3 revenue surged 81% to $26.9M, but margins fell; Q4 guidance: $31.5M–$33.5M.NNDM
Q3 2025 - Record Q2 revenue, improved margins, and a transformative acquisition highlight best quarter.NNDM
Q2 2024